Management of Primary Central Nervous System Lymphoma Using Intra-Arterial Chemotherapy With Osmotic Blood-Brain Barrier Disruption: Retrospective Analysis of the Sherbrooke Cohort
出版年份 2021 全文链接
标题
Management of Primary Central Nervous System Lymphoma Using Intra-Arterial Chemotherapy With Osmotic Blood-Brain Barrier Disruption: Retrospective Analysis of the Sherbrooke Cohort
作者
关键词
-
出版物
Frontiers in Oncology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-01-20
DOI
10.3389/fonc.2020.543648
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The possible role of maintenance treatment for primary central nervous system lymphoma
- (2018) Osnat Bairey et al. BLOOD REVIEWS
- A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome
- (2018) Narayan Adhikari et al. JOURNAL OF NEURO-ONCOLOGY
- Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL
- (2018) Michele Da Broi et al. BLOOD CELLS MOLECULES AND DISEASES
- Is whole-brain radiotherapy still a standard treatment for primary central nervous system lymphomas?
- (2018) Uwe Schlegel et al. CURRENT OPINION IN NEUROLOGY
- The elderly left behind—changes in survival trends of primary central nervous system lymphoma over the past 4 decades
- (2017) Joe S Mendez et al. NEURO-ONCOLOGY
- Epidemiology for primary brain tumors: a nationwide population-based study
- (2016) Amélie Darlix et al. JOURNAL OF NEURO-ONCOLOGY
- Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
- (2016) Andrés J M Ferreri et al. Lancet Haematology
- Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous
- (2015) Annie Drapeau et al. CURRENT CANCER DRUG TARGETS
- Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
- (2015) Khê Hoang-Xuan et al. LANCET ONCOLOGY
- Impact of Drug Size on Brain Tumor and Brain Parenchyma Delivery after a Blood–Brain Barrier Disruption
- (2014) Marie Blanchette et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Primary CNS Lymphoma
- (2014) Elizabeth H. Phillips et al. Current Hematologic Malignancy Reports
- How I treat CNS lymphomas
- (2013) J. L. Rubenstein et al. BLOOD
- Preservation of Cognitive Function in Primary CNS Lymphoma Survivors a Median of 12 Years After Enhanced Chemotherapy Delivery
- (2013) Nancy D. Doolittle et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome
- (2013) Patrick G. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Imaging and Therapy with Rituximab Anti-CD20 Immunotherapy in an Animal Model of Central Nervous System Lymphoma
- (2011) L. L. Muldoon et al. CLINICAL CANCER RESEARCH
- Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?
- (2010) Antonio Omuro et al. JOURNAL OF NEURO-ONCOLOGY
- High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
- (2010) Eckhard Thiel et al. LANCET ONCOLOGY
- Addressing Central Nervous System (CNS) Penetration in Drug Discovery: Basics and Implications of the Evolving New Concept
- (2009) Andreas Reichel CHEMISTRY & BIODIVERSITY
- Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience
- (2009) Lilyana Angelov et al. JOURNAL OF CLINICAL ONCOLOGY
- Maintenance therapy for central nervous system lymphoma with rituximab
- (2009) Douglas E. Ney et al. LEUKEMIA & LYMPHOMA
- REAL-TIME MONITORING OF GADOLINIUM DIETHYLENETRIAMINE PENTA-ACETIC ACID DURING OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION USING MAGNETIC RESONANCE IMAGING IN NORMAL WISTAR RATS
- (2009) Marie Blanchette et al. NEUROSURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now